2020.10.07

Notification of the commencement of the Phase III clinical study of HP-5070 in Japan (primary palmar hyperhidrosis treatment drug)

2020.09.10

Notice Regarding Resignation of Board of Director and Post After ResignationNotification of application for manufacturing and marketing approval of the additional indications of cancer pain relief for pediatric patients of Fentos_®Tape (Transdermal, pain management patch,Development code: HFT-290) in Japan

2020.07.29

Notice Regarding Resignation of Board of Director and Post After Resignation

2020.07.21

Notification of approval for manufacturing and marketing approval of OABLOK_® PATCH in Thailand (Transdermal, Overactive bladder treatment patch)

2020.07.09

FY02/2021 Q1 Results Earnings Release Presentation